|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.180 USD | 0.00% |
|
-11.81% | -42.02% |
EPS & Dividend: Altimmune, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.91 | -2.35 | -1.81 | -1.66 | -1.34 | -1.28 | -1.533 | -1.351 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 11.280 | 9.160 | 16.450 | 11.250 | 7.210 | 4.180 | 4.180 | 4.180 |
| Nbr of stocks (in thousands) | 36,968 | 39,644 | 49,146 | 53,729 | 71,125 | 81,107 | - | - |
| Announcement Date | 2/25/21 | 3/15/22 | 2/28/23 | 3/27/24 | 2/27/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Altimmune, Inc.
| 2025-08-06 | Q2 2025 Earnings Release (Projected) |
| 2025-11-10 | Q3 2025 Earnings Release (Projected) |
| 2026-03-25 | Q4 2025 Earnings Release (Projected) |
| 2026-05-18 | Q1 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -3.27x | 4.19x | 378.27x | ||
| -.--% | -.--% | 49.61x | 5.42x | 8.53x | ||
| 1.52% | 1.72% | 18.99x | 3.37x | 4.74x | ||
| -.--% | -.--% | -23.89x | 1.29x | 5.93x | ||
| -.--% | -.--% | -66.37x | - | - | ||
| -.--% | -.--% | -19.64x | 58.12x | 43.76x | ||
| -.--% | -.--% | 1188.59x | 15.01x | 29.12x | ||
| -.--% | -.--% | 25.79x | 2.15x | 4.53x | ||
| -.--% | -.--% | 13.78x | 2.16x | 2.73x | ||
| -.--% | -.--% | 19.46x | 4.38x | 4.69x | ||
| Average | 0.15% | 0.17% | 120.30x | 10.68x | 53.59x | |
| Weighted average by Cap. | 0.25% | 0.29% | 93.96x | 10.78x | 12.98x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition